CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy
Fabiana Dalla Vecchia Genvigir Antony Brayan Campos-Salazar; Claudia Rosso Felipe; Helio Tedesco Silva Junior; José Osmar Medina Pestana; Sonia de Quateli Doi; Alvaro Cerda; Mario Hiroyuki Hirata; María José Herrero; Rosario Dominguez Crespo Hirata
Pharmacogenomics London v. 21, n. 1, p. 7-21, 2020London 2020
Item não circula. Consulte sua biblioteca.(Acessar)